Literature DB >> 33159262

The Effect of Naja naja oxiana Snake Venom Against Leishmania tropica Confirmed by Advanced Assays.

Iraj Sharifi1, Fatemeh Tabatabaie2, Saeideh Nikpour3, Mahshid Mostafavi1, Razieh Tavakoli Oliaee1, Fatemeh Sharifi4, Zahra Babaei1, Elham Jafari5, Ehsan Salarkia1, Delavar Shahbazzadeh6.   

Abstract

PURPOSE: The aim of this study was to explore the activity of Naja naja oxiana venom on Leishmania tropica and its modes of action.
METHODS: Different fractions of Naja naja oxiana venom (NNOV) were prepared and characterized by high-performance liquid chromatography. The superior component, fraction k (FK) was selected. The activity of the fraction was assessed using advanced assays.
RESULTS: Interleukin (IL)-12, TNF-α and iNOS gene expression as the indicators of Th1 significantly increased. In contrast, the level of IL-10, as the marker of T helper 2 substantially decreased (p < 0.001). Reactive oxygen species (ROS) detection showed a significant increase (p < 0.001) after treatment with different concentrations of NNOV-FK, unlike arginase (L-ARG) activity which showed a significant reduction (p < 0.001). The NNOV-FK showed significant lethal activity on the L. tropica stages.
CONCLUSION: The findings demonstrated that NNOV-FK represented a strong leishmanicidal activity on L. tropica stages. The major modes of NNOV-FK action are multidimensional, which perceives the induction of a synergistic response and upregulation of the immune-modulatory role towards Th1 response against L. tropica stages as well as apoptotic and anti-metabolic action as a model drug to generate ROS, block the polyamine synthesis and lead to parasite death.

Entities:  

Keywords:  Leishmania tropica; Leishmanicidal effect; Mechanism of action; Snake venom fractions

Year:  2020        PMID: 33159262     DOI: 10.1007/s11686-020-00301-3

Source DB:  PubMed          Journal:  Acta Parasitol        ISSN: 1230-2821            Impact factor:   1.440


  49 in total

1.  Metabolism of 2-substituted quinolines with antileishmanial activity studied in vitro with liver microsomes, hepatocytes and recombinantly expressed enzymes analyzed by LC/MS.

Authors:  Julie Desrivot; Per-Olof Edlund; Richard Svensson; Pawel Baranczewski; Alain Fournet; Bruno Figadère; Christine Herrenknecht
Journal:  Toxicology       Date:  2007-03-12       Impact factor: 4.221

2.  Leishmaniasis and poverty.

Authors:  Jorge Alvar; Sergio Yactayo; Caryn Bern
Journal:  Trends Parasitol       Date:  2006-10-04

3.  Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study.

Authors:  Jaime M Soto; Julia T Toledo; Patricia Gutierrez; Margarita Arboleda; Ruben S Nicholls; Julio R Padilla; Jonathan D Berman; Charles K English; Max Grogl
Journal:  Am J Trop Med Hyg       Date:  2002-02       Impact factor: 2.345

4.  Pentoxifylline prevents the meglumine antimonate-induced renal toxicity in rats, but not that induced by the inorganic antimony pentachloride.

Authors:  Flávio José Dutra de Moura; Pushkin Pires Leal; Rogério de Souza Furtado; Maria Imaculada Muniz-Junqueira; Joel Paulo Russomano Veiga
Journal:  Toxicology       Date:  2007-10-07       Impact factor: 4.221

Review 5.  The antioxidant role of selenium and seleno-compounds.

Authors:  H Tapiero; D M Townsend; K D Tew
Journal:  Biomed Pharmacother       Date:  2003 May-Jun       Impact factor: 6.529

6.  Vascular apoptosis associated with meglumine antimoniate: In vivo investigation of a chick embryo model.

Authors:  Ahmad Khosravi; Iraj Sharifi; Hadi Tavakkoli; Ali Reza Keyhani; Ali Afgar; Zohreh Salari; Seyedeh Saedeh Mosallanejad; Mehdi Bamorovat; Fatemeh Sharifi; Saeid Hassanzadeh; Balal Sadeghi; Shahriar Dabiri; Abbas Mortazaeizdeh; Zahra Sheikhshoaie; Ehsan Salarkia
Journal:  Biochem Biophys Res Commun       Date:  2018-10-05       Impact factor: 3.575

7.  Leishmaniasis worldwide and global estimates of its incidence.

Authors:  Jorge Alvar; Iván D Vélez; Caryn Bern; Mercé Herrero; Philippe Desjeux; Jorge Cano; Jean Jannin; Margriet den Boer
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

8.  A new perspective on cutaneous leishmaniasis-Implications for global prevalence and burden of disease estimates.

Authors:  Freddie Bailey; Karina Mondragon-Shem; Peter Hotez; José Antonio Ruiz-Postigo; Waleed Al-Salem; Álvaro Acosta-Serrano; David H Molyneux
Journal:  PLoS Negl Trop Dis       Date:  2017-08-10

9.  Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran.

Authors:  Mohammad Reza Aflatoonian; Iraj Sharifi; Behnaz Aflatoonian; Mehdi Bamorovat; Amireh Heshmatkhah; Zahra Babaei; Pooya Ghasemi Nejad Almani; Mohammad Ali Mohammadi; Ehsan Salarkia; Abbas Aghaei Afshar; Hamid Sharifi; Fatemeh Sharifi; Ahmad Khosravi; Mehrdad Khatami; Nasir Arefinia; Alireza Fekri; Saeideh Farajzadeh; Ali Khamesipour; Mehdi Mohebali; Mohammad Mehdi Gouya; Mohammad Reza Shirzadi; Rajender S Varma
Journal:  PLoS Negl Trop Dis       Date:  2019-06-12

10.  Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran.

Authors:  Mehdi Bamorovat; Iraj Sharifi; Mohammad Reza Aflatoonian; Hamid Sharifi; Ali Karamoozian; Fatemeh Sharifi; Ahmad Khosravi; Saeid Hassanzadeh
Journal:  PLoS One       Date:  2018-02-07       Impact factor: 3.240

View more
  1 in total

Review 1.  Antiprotozoal Effect of Snake Venoms and Their Fractions: A Systematic Review.

Authors:  Zainab U Abdullahi; Salihu S Musa; Daihai He; Umar M Bello
Journal:  Pathogens       Date:  2021-12-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.